Table of Contents

April 25, 2002
Volume 45, Issue 9
Pages 1737-1958

Letters

A Computational Ensemble Pharmacophore Model for Identifying Substrates of P-Glycoprotein

pp 1737–1740
Publication Date (Web): March 26, 2002 (Letter)
DOI: 10.1021/jm0255062

Articles

Structure-Based Design and Synthesis of 2-Benzylidene-benzofuran-3-ones as Flavopiridol Mimics

pp 1741–1747
Publication Date (Web): March 26, 2002 (Article)
DOI: 10.1021/jm0108348

Exploration of the Pharmacophore of 3-Alkyl-5-Arylimidazolidinediones as New CB1 Cannabinoid Receptor Ligands and Potential Antagonists: Synthesis, Lipophilicity, Affinity, and Molecular Modeling

pp 1748–1756
Publication Date (Web): March 26, 2002 (Article)
DOI: 10.1021/jm010896y

Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors

pp 1757–1766
Publication Date (Web): March 26, 2002 (Article)
DOI: 10.1021/jm0109513

Vinyl Sulfide Cyclized Analogues of Angiotensin II with High Affinity and Full Agonist Activity at the AT1 Receptor

pp 1767–1777
Publication Date (Web): March 30, 2002 (Article)
DOI: 10.1021/jm011063a

Binding Mode Analysis of 3-(4-Benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide:  A New Synthetic Histone Deacetylase Inhibitor Inducing Histone Hyperacetylation, Growth Inhibition, and Terminal Cell Differentiation

pp 1778–1784
Publication Date (Web): March 26, 2002 (Article)
DOI: 10.1021/jm011088+

Investigation of Potential Bioisosteric Replacements for the Carboxyl Groups of Peptidomimetic Inhibitors of Protein Tyrosine Phosphatase 1B:  Identification of a Tetrazole-Containing Inhibitor with Cellular Activity

pp 1785–1798
Publication Date (Web): March 29, 2002 (Article)
DOI: 10.1021/jm011100y

Identification of Nonpeptidic Urotensin II Receptor Antagonists by Virtual Screening Based on a Pharmacophore Model Derived from Structure−Activity Relationships and Nuclear Magnetic Resonance Studies on Urotensin II

pp 1799–1805
Publication Date (Web): March 20, 2002 (Article)
DOI: 10.1021/jm0111043

Cyclodextrin-Derived Host Molecules as Reversal Agents for the Neuromuscular Blocker Rocuronium Bromide:  Synthesis and Structure−Activity Relationships

pp 1806–1816
Publication Date (Web): March 21, 2002 (Article)
DOI: 10.1021/jm011107f

Polysaccharide−Oligoamine Based Conjugates for Gene Delivery

pp 1817–1824
Publication Date (Web): March 29, 2002 (Article)
DOI: 10.1021/jm0105528

Rational Design, Synthesis, and Biological Activity of Novel Conformationally Restricted Vitamin D Analogues, (22R)- and (22S)-22-Ethyl-1,25-dihydroxy-23,24-didehydro-24a,24b-dihomo-20-epivitamin D3

pp 1825–1834
Publication Date (Web): March 27, 2002 (Article)
DOI: 10.1021/jm0105631

Preparation and Characterization of Platinum(II) and (IV) Complexes of 1,3-Diaminepropane and 1,4-Diaminebutane:  Circumvention of Cisplatin Resistance and DNA Interstrand Cross-Link Formation in CH1cisR Ovarian Tumor Cells

pp 1835–1844
Publication Date (Web): March 20, 2002 (Article)
DOI: 10.1021/jm010968l

5‘-Deoxy Congeners of 9-(3-Amido-3-deoxy-β-d-xylofuranosyl)-N6-cyclopentyladenine:  New Adenosine A1 Receptor Antagonists and Inverse Agonists

pp 1845–1852
Publication Date (Web): March 16, 2002 (Article)
DOI: 10.1021/jm0110439

Synthesis of Nitroindole Derivatives with High Affinity and Selectivity for Melatoninergic Binding Sites MT3

pp 1853–1859
Publication Date (Web): March 27, 2002 (Article)
DOI: 10.1021/jm011053+

Structure−Activity Relationships of Methoctramine-Related Polyamines as Muscular Nicotinic Receptor Noncompetitive Antagonists. 2.1 Role of Polymethylene Chain Lengths Separating Amine Functions and of Substituents on the Terminal Nitrogen Atoms

pp 1860–1878
Publication Date (Web): March 21, 2002 (Article)
DOI: 10.1021/jm011067f

Halogenated Diazirines as Photolabel Mimics of the Inhaled Haloalkane Anesthetics

pp 1879–1886
Publication Date (Web): March 28, 2002 (Article)
DOI: 10.1021/jm0104926

3-Heteroaryl-2-pyridones:  Benzodiazepine Site Ligands with Functional Selectivity for α2/α3-Subtypes of Human GABAA Receptor-Ion Channels

pp 1887–1900
Publication Date (Web): March 29, 2002 (Article)
DOI: 10.1021/jm0110789

Synthesis and Biological Evaluation of Structurally Highly Modified Analogues of the Antimitotic Natural Product Curacin A

pp 1901–1917
Publication Date (Web): March 28, 2002 (Article)
DOI: 10.1021/jm0105171

6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with Antiviral Activity

pp 1918–1929
Publication Date (Web): March 27, 2002 (Article)
DOI: 10.1021/jm011095y

Further Studies on Conformationally Constrained Tricyclic Tropane Analogues and Their Uptake Inhibition at Monoamine Transporter Sites:  Synthesis of (Z)-9-(Substituted arylmethylene)-7-azatricyclo[4.3.1.03,7]decanes as a Novel Class of Serotonin Transporter Inhibitors

pp 1930–1941
Publication Date (Web): March 27, 2002 (Article)
DOI: 10.1021/jm0105373

Synthesis of N-[4-[1-Ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic Acid as an Antifolate1

pp 1942–1948
Publication Date (Web): March 21, 2002 (Article)
DOI: 10.1021/jm010575m

Studies on the Synthesis and Opioid Agonistic Activities of Mitragynine-Related Indole Alkaloids:  Discovery of Opioid Agonists Structurally Different from Other Opioid Ligands

pp 1949–1956
Publication Date (Web): March 20, 2002 (Article)
DOI: 10.1021/jm010576e

Additions and Corrections

2,4-Diaminothieno[2,3-d]pyrimidine Lipophilic Antifolates as Inhibitors of Pneumocystis carinii and Toxoplasma gondii Dihydrofolate Reductase.

p 1957
Publication Date (Web): March 14, 2002 (Addition/Correction)
DOI: 10.1021/jm020059b

2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine Analogues of Trimethoprim as Inhibitors of Pneumocystis carinii and Toxoplasma gondii Dihydrofolate Reductase.

p 1957
Publication Date (Web): March 14, 2002 (Addition/Correction)
DOI: 10.1021/jm020060a

Synthesis and Antiparasitic and Antitumor Activity of 2,4-Diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline Analogues of Piritrexim.

pp 1957–1958
Publication Date (Web): March 14, 2002 (Addition/Correction)
DOI: 10.1021/jm0200613

Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development.

p 1958
Publication Date (Web): April 18, 2002 (Addition/Correction)
DOI: 10.1021/jm000383b